SIRIC: All components to transform world-class cancer research into comprehensive care
A label of excellence for multidisciplinary and integrated research
The National Cancer Institute has established a competitive policy of labelling Integrated Cancer Research Site (SIRIC). Their objective:
1) to provide new operational conditions for translational research in cancerology, in order to optimize and accelerate the production of new knowledge
2) to promote the dissemination and application of this knowledge in the treatment of cancer.
Veritable concentration of skills, SIRIC Montpellier Cancer brings together more than a thousand professionals from the university hospitals of Montpellier as well as public research organisations and Montpellier’s higher education faculties. Through the diverse approaches of its laboratories, the SIRIC consortium covers the whole range of research for which the ultimate goal is the improved understanding, prevention, detection and treatment of cancer.
After an initial call for applications launched in 2011, the INCa certified 8 SIRICs in France in 2012. Following a new call, the INCa renewed the labeling of eight SIRICs in 2017 for five years. SIRIC funding is provided jointly by an endowment from the INCa, the Ministry of Health (DGOS) and Inserm on behalf of the Alliance for Life Sciences and Health (Aviesan).